By SmokerBar Editorial Team

If you are an adult considering VELO nicotine pouches, you have likely asked the same question health authorities and researchers are debating in 2026: Are VELO pouches toxic?

The short answer is nuanced. According to a December 2025 expert consensus report in the European Heart Journal, nicotine itself is a direct cardiovascular toxin, regardless of delivery method — whether from cigarettes, vapes, or oral nicotine pouches. However, the same report acknowledges that while nicotine pouches like VELO deliver toxic doses of nicotine that impair vascular health, they contain dramatically lower levels of other harmful constituents compared to combustible cigarettes.

In this 2026 guide, we will separate fact from marketing — examining what makes VELO toxic, who is most at risk, and how to use it responsibly if you are an adult smoker.

What Actually Goes Into a VELO Pouch?

VELO nicotine pouches are small, fiber-based pouches placed between the gum and upper lip. Unlike cigarettes or traditional chewing tobacco, VELO contains no tobacco leaf and involves no combustion. The ingredients include:

• Pharmaceutical‑grade nicotine (derived from tobacco or synthesized in a lab)

• Plant‑based fibers

• Water

• Food‑grade flavorings (mint, fruit, berry, and tropical blends)

• Sweeteners (including sucralose and acesulfame‑K)

• pH adjusters (to optimize nicotine absorption)

While VELO products are reported to contain 99% fewer toxicants than a cigarette, they are not risk‑free. The company itself states that VELO pouches are “made with top‑notch ingredients” and contain “no tobacco, no smoke, no smell, no vapour”. But the Rhode Island Department of Health — and similar public health bodies — caution: “They are often marketed as an alternative to smoking or vaping, but that does not mean they are harmless. These tobacco products contain nicotine, which is addictive and dangerous to developing brains. Nicotine pouches can also poison babies, toddlers, and pets who may accidentally eat them.”

The Toxicology of VELO: What the 2026 Research Shows

Artificial Sweeteners and Product Appeal

A January 2026 Duke University study analyzed artificial sweeteners in US‑marketed nicotine pouches, including VELO. The researchers found:

• Acesulfame‑K was detected in VELO pouches at approximately 0.3 to 0.9 mg per pouch

• Sucralose was found in VELO pouches at 0.6 to 1.2 mg per pouch, with higher nicotine‑strength products containing higher sucralose levels

• The study concluded that artificial sweeteners in ONPs “reduce aversion, facilitate initiation, and encourage consumption behavior,” with sweetness “likely reducing the aversive sensory effects of nicotine”

The researchers warned that sweeteners in tobacco products need to be addressed by regulators “to reduce product appeal and initiation by never users, and especially youth attracted to sweet flavors”.

Toxicant Content: VELO vs. Cigarettes

A 2025 CORESTA study comparing 132 analytes across nicotine pouches, snus, and cigarette smoke found that VELO products contained significantly lower levels of harmful constituents than both cigarettes and Swedish snus. The results showed that:

• 70 analytes were not quantified in any ONP samples tested

• Fewer analytes were present at quantifiable levels in ONPs (47) than in snus (58)

• In most tests, ONPs contained lower levels of analytes (>90%) than snus

A 2025 clinical study in which adult smokers switched exclusively to VELO nicotine pouches for five days found average reductions in toxicant exposure between 29% and 97% across all VELO users, including a statistically significant reduction in exposure to the lung carcinogen NNK.

What the 2026 Review Concludes

A February 2026 narrative review in Internal and Emergency Medicine assessed the current scientific evidence on nicotine pouches. The review concluded that:

• Chemical analyses and biomarker studies “consistently demonstrate that these products occupy the lowest end of the toxicant risk continuum”

• Harmful constituents such as tobacco‑specific nitrosamines are “largely undetectable or present at negligible levels compared to snus and combustible cigarettes”

• Smokers who switch to nicotine pouches experience “reductions in toxicant exposure comparable to complete smoking cessation”

However, the review also noted that “specific long‑term epidemiological data are currently unavailable,” and called for “product‑specific research and epidemiological surveillance” to confirm their long‑term safety profile.

The Heart of the Matter: Nicotine Is a Cardiovascular Toxin

The most significant health risk from VELO — and all nicotine products — is the nicotine itself. A December 2025 expert consensus report published in the European Heart Journal delivered an unambiguous conclusion:

“Nicotine is not a harmless stimulant; it is a direct cardiovascular toxin.”

The report found that regardless of how nicotine is delivered — whether through cigarettes, vapes, heated tobacco, or oral nicotine pouches — the toxic effects on the heart and blood vessels include:

• Triggering acute increases in heart rate and blood pressure

• Impairing the ability of blood vessels to expand and contract

• Promoting blood clots, increasing heart attack and stroke risk

• Causing scarring to the heart

• Promoting growth of new blood vessels, which can feed cancers

Lead researcher Dr. Thomas Münzel stated: “Across cigarettes, vapes, heated tobacco and nicotine pouches, we consistently see increased blood pressure, damage to blood vessels and a higher risk of heart disease. No product that delivers nicotine is safe for the heart.”

Professor Thomas Lüscher, a consultant cardiologist, called the report “a wake‑up call for regulators,” adding: “The shift from cigarettes to e‑cigarettes and flavored pouches is no effective harm reduction; it is rather a transformation of addiction strategies.”

What This Means for VELO Users

If you are an adult smoker who switches completely from cigarettes to VELO, you eliminate exposure to tar, carbon monoxide, and thousands of combustion‑related toxins — a significant health improvement. However, you still expose your cardiovascular system to nicotine, which carries its own risks. As the GP Cardiology summary of the same report concluded: “No ‘safe’ nicotine product: There is no safe form of nicotine for the heart or blood vessels”.

Youth and Young Adults: Why Nicotine Is Especially Toxic for Developing Brains

Health authorities in 2026 are particularly concerned about nicotine pouch use among young people — not because the pouches contain unique toxins, but because developing brains are exquisitely sensitive to nicotine.

The NSW Health fact sheet (updated February 2026) warns:

• A single nicotine pouch can contain up to 20 mg of nicotine, which is equal to about 20 cigarettes

• Nicotine can negatively impact brain development affecting learning, concentration, memory, mood, and decision‑making

• Nicotine pouches are “highly addictive and can lead to nicotine dependence”

A 2026 article in The Sydney Morning Herald quotes Amie J. Miller, APRN, of the Brian D. Jellison Cancer Institute: “Nicotine is particularly toxic for younger populations” with significant effects on brain development and mental health. Studies show that nicotine can impair brain development even into the mid‑20s and can intensify symptoms of depression and anxiety, as well as increase stress levels, despite often being portrayed as a stress reliever.

Miller explains the mechanism: “Nicotine hijacks the brain’s stress response, creating a chemical trap that mimics anxiety relief while actually fueling it” by triggering the release of both dopamine (which feels good) and cortisol (the body’s primary stress regulator). Instead of calming nerves, nicotine actually keeps the body in a “state of heightened physiological stress, thinking more nicotine is the only answer”.

The American Lung Association (February 2026) adds that nicotine exposure is “especially damaging to children and teenagers whose brains are still developing. It affects the brain’s ability to retain information and can lead to attention problems. It affects impulse control so it can cause the same effects as ADHD or make ADHD even worse”.

The Takeaway for Young People

If you are under 25, do not start using VELO or any nicotine product. The risks to your brain development, mental health, and future addiction potential are significant and well‑documented. As Miller concluded: “Nicotine products have also grown stronger... Dependence then develops quickly, and withdrawal symptoms like irritability, anxiety, dysphoria, and impaired concentration make quitting difficult. Early exposure only increases this addiction risk”.

Oral Health: What Happens to Your Mouth?

Because VELO pouches sit directly against the gum tissue, oral health is a legitimate concern. A February 2026 Frontiers in Oral Health mini‑review found:

• Toxicological analyses reveal significantly lower levels of harmful constituents relative to cigarettes and traditional smokeless tobacco

• Short‑term clinical studies report reductions in oral mucosal irritation and gingival inflammation among exclusive pouch users

• However, no long‑term epidemiological evidence is currently available to assess the potential impact of nicotine pouches on oral carcinogenesis

Nicotine is a vasoconstrictor, meaning it narrows blood vessels and reduces blood flow to the gums. This can lead to localized irritation, gum recession, and dry mouth over time. Users who do not rotate placement (alternating between left and right sides of the upper lip) are at higher risk.

As the February 2026 NSW Health fact sheet states: “Because pouches sit in the mouth, there are concerns this could lead to long term oral health problems”.

Poisoning Risk: Children, Toddlers, and Pets

One of the most serious toxicological concerns with VELO and all nicotine pouches is accidental ingestion by children or pets. This is not a hypothetical risk — data from U.S. Poison Centers confirm it is happening with increasing frequency.

Children

According to the FDA (updated September 2025):

• During the three‑year period of April 2022 to March 2025, nicotine pouch exposure cases reported to U.S. Poison Centers steadily increased

• Approximately 72% of reported nicotine pouch exposure cases occurred in children under 5 years of age

• Ingestion was the reported route of exposure for almost all cases (99%) pertaining to nicotine pouch products

The harmful effects of nicotine poisoning in children vary but may include confusion, vomiting, and loss of consciousness. The FDA notes that nicotine pouch containers — with bright, colorful designs — “may seem tempting to children” and “can even resemble candy containers”.

If a child cannot wake up, is having trouble breathing, or has a seizure after potential nicotine pouch ingestion, call 911 immediately. For less severe cases, contact the Poison Help Line at 1‑800‑222‑1222.

Pets

Nicotine is also highly toxic to dogs and cats. According to veterinary sources:

• The first signs of nicotine poisoning in pets include drooling, vomiting, diarrhea, and agitation, followed by lethargy, tremors, rapid breathing, and muscle weakness

• Clinical signs can occur when dogs ingest doses as low as 1 mg of nicotine per kilogram of body weight

• If a dog ingests 9 to 12 mg of nicotine per kilogram, they could be at risk of death

• Nicotine is rapidly absorbed, and its effects can last for up to 24 hours

If your pet eats a nicotine pouch, contact your veterinarian immediately. Do not wait for symptoms to appear.

Safe Storage Guidelines

The FDA recommends:

• Keep nicotine pouch containers out of reach and view of children and pets, such as in a high cabinet that locks

• Fully close the container and engage any child‑resistant features when not in use

• Store pouches in their original containers — avoid transferring to other containers that may not be child‑resistant

• Do not use nicotine pouches in front of children

• Explain to children that these products should not be touched and should only be handled by adults

VELO vs. Cigarettes: Putting “Toxicity” in Perspective

To understand VELO’s toxicity, it helps to compare it to the product most adult users are switching from: cigarettes.

A 2025 Frontiers in Pharmacology study on Velo ONPs found that abuse liability (addiction potential) of Velo was significantly lower than cigarettes and similar to nicotine replacement therapy gum. Nicotine uptake with Velo was slower and had lower peak concentrations than cigarettes, further supporting their potential as a lower‑risk alternative.

The key distinction is that cigarettes combine nicotine toxicity with combustion‑related toxins (tar, carbon monoxide, thousands of carcinogens). VELO isolates nicotine toxicity while eliminating combustion. For adult smokers who cannot or will not quit nicotine, switching completely to VELO represents a meaningful reduction in toxicant exposure. But for non‑users, VELO offers no health benefits — only risks.

2026 Regulatory Update: FDA Caution on Youth and New Users

As of April 2026, the FDA’s fast‑track nicotine pouch approval scheme has been slowed by concerns about risks to youth and new users. According to Reuters reporting:

• Applications for newer versions of VELO (along with Zyn) remain pending despite the fast‑track effort

• The FDA is taking a cautious approach, weighing whether products can help smokers switch “while not driving risks too high for non‑tobacco users and children”

• Specific concerns relate to “risks to youth or other non‑users, such as driving addiction in adults who do not already smoke”

The FDA states that “nicotine products are highly addictive and are not risk‑free even for adults, while nicotine can harm developing brains,” while acknowledging that pouches “are generally less harmful than cigarettes”.

BAT, the manufacturer of VELO, has stated that its applications “warrant the agency’s authorization given robust scientific support, and it continues to engage constructively with the FDA”.

Who Should Use VELO? (And Who Should Absolutely Not)

Based on the 2026 evidence, here is a clear guidance framework:

VELO May Be Appropriate For:

• Adult smokers (18+ or 21+ depending on local laws) who have tried to quit using other methods and would otherwise continue smoking

• Adults who understand that nicotine is addictive and carries cardiovascular risks

• Adults who will switch completely from cigarettes (not dual use)

VELO Is NOT Appropriate For:

• Anyone under 25 (nicotine harms developing brains)

• Non‑nicotine users of any age

• Pregnant or breastfeeding women

• Individuals with heart disease, high blood pressure, or other cardiovascular conditions

• Anyone who would use VELO while continuing to smoke or vape (dual use provides minimal health benefit)

As the NSW Health fact sheet concludes: “Nicotine pouches are not safe and are a risk to your health... Nicotine can negatively impact your brain development affecting learning, concentration, memory, mood and decision making”.

How to Minimise Risks If You Choose to Use VELO

If you are an adult smoker who has decided to switch to VELO, follow these evidence‑based guidelines to minimise risks:

1. Switch completely — Dual use (smoking while using pouches) does not provide the same toxicant reduction benefits. The biomarker study showed significant reductions only among exclusive VELO users.

2. Start with the lowest effective strength — VELO offers 4 mg, 6 mg, 8 mg, 10 mg, and higher options. Lower strengths mean lower nicotine exposure.

3. Rotate placement — Alternate between left and right sides of your upper lip to prevent localized gum irritation and recession.

4. Limit duration — Do not keep a pouch in for more than 30–45 minutes.

5. Stay hydrated — Drink water to counteract dry mouth.

6. Maintain oral hygiene — Brush twice daily and visit your dentist regularly.

7. Store safely — Keep VELO cans out of reach of children and pets in a locked cabinet. Never leave pouches unattended around young children or animals.

8. Dispose properly — Use the built‑in catch lid compartment or a trash bin. Never flush pouches down the toilet.

9. Monitor your health — If you experience persistent heart palpitations, chest pain, or significant gum issues, discontinue use and consult a healthcare professional.

Final Verdict: Are VELO Nicotine Pouches Toxic?

Yes — VELO nicotine pouches contain nicotine, which is a direct cardiovascular toxin. However, the toxicological profile of VELO is substantially less concerning than that of combustible cigarettes, as it eliminates tar, carbon monoxide, and thousands of combustion‑related carcinogens.

For adult smokers who switch completely, the 29–97% reduction in toxicant exposure observed in clinical studies represents a meaningful health improvement. For everyone else — youth, young adults, non‑users, pregnant women, and those with heart conditions — VELO offers no benefits and only risks.

The Rhode Island Department of Health’s warning remains accurate and important: “They are often marketed as an alternative to smoking or vaping, but that does not mean they are harmless.”

Shop Authentic VELO Nicotine Pouches at SmokerBar

At SmokerBar, we carry authentic VELO nicotine pouches in various strengths (4 mg to 17 mg) and flavours — Polar Mint, Ruby Berry, Tropic Breeze, Freezing Peppermint, and more. All products are sourced directly from authorised distributors, stored fresh, and shipped discreetly with age verification (18+ or 21+ depending on local laws).

We also sell child‑resistant locking storage boxes designed specifically for nicotine pouches — helping you keep your products safely out of reach of children and pets.

Browse our VELO collection today — and use responsibly.

Disclaimer: This product contains nicotine. Nicotine is an addictive chemical and a cardiovascular toxin. For adult smokers aged 18+ only. Keep out of reach of children and pets. This article is for informational purposes and does not constitute medical advice. If you do not use nicotine, do not start. If you are pregnant, breastfeeding, or have a heart condition, consult a healthcare professional before use.